Cross-institution positioning
Sep 8, 2026Mixed positioning. 1 accumulating, 1 reducing, 4 exited across 6 comparable institutions.
Source: Schedule 13 researchBlue Bird Corp
Latest stored close $56.29 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Mixed positioning. 1 accumulating, 1 reducing, 4 exited across 6 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 1 purchase by 1 reporting owner and 1 sale by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/55 non-amendment material events in the last 90 days; 2 capital-related filing/events (0 equity-related, 1 debt-related); Latest classified evidence: Material definitive agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +29.9% YoY; Net income +408.2% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 42% through its reported 52-week range; +9.9% over one year.
Source: Stored historical price seriesFiled Sep 8, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sanfrey Jeffrey Scott | SOpen-market or private sale | Common Stock, par value $0.0001 per share | 4.0K | $62.40 | Direct | Sep 18, 2026 |
| Aug 12, 2026 | Thau Daniel Mark | POpen-market or private purchase | Common Stock, par value $0.0001 per share | 350 | $64.37 | Direct | Aug 13, 2026 |
| May 19, 2026 | Thau Daniel Mark | POpen-market or private purchase | Common Stock, par value $0.0001 per share | 300 | $65.09 | Direct | May 20, 2026 |
| Apr 1, 2026 | Girardin Steve | AGrant, award, or other acquisition · derivative | Exchangeable Shares | 2.7M | — | Indirect | Apr 9, 2026 |
| Apr 1, 2026 | Girardin Steve | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 9, 2026 |
| Apr 1, 2026 | Girardin Steve | AGrant, award, or other acquisition | Special Voting Preferred Stock | 1 | — | Indirect | Apr 9, 2026 |
| Apr 1, 2026 | Penn Kevin S. | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
| Apr 1, 2026 | Thau Daniel Mark | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
| Apr 1, 2026 | Newman Simon J | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
| Apr 1, 2026 | Hightower Edward T. | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
| Apr 1, 2026 | Grimm Douglas J. | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
| Apr 1, 2026 | Fream Julie A | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
| Apr 1, 2026 | Blaufuss Mark | AGrant, award, or other acquisition | Common Stock, par value $0.0001 per share | 2.3K | $0.00 | Direct | Apr 2, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Oct 6, 2026 | 8-K | 1.01, 2.03, 7.01, 9.01 | Material definitive agreement; New direct financial obligation; Regulation FD disclosure; Financial statements / exhibits | Debt | Filing |
| Oct 1, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Oct 1, 2026 | 424B7 | — | Prospectus filing | Capital-related | Filing |
| Aug 5, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Aug 5, 2026 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 18, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| May 6, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| May 6, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| May 4, 2026 | 8-K/AAmendment | 5.02 | Director or executive change | — | Filing |
| Apr 2, 2026 | 8-K | 2.01, 3.02, 5.02, 5.03, 7.01, 9.01 | Acquisition or disposition of assets; Unregistered sale of equity securities; Director or executive change; Charter or bylaw change; Regulation FD disclosure; Financial statements / exhibits | Equity | Filing |
| Mar 11, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
| Feb 17, 2026 | 8-K | 1.01, 7.01, 9.01 | Material definitive agreement; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 27, 2026 | $517.2M | +29.9% |
| Ended Mar 28, 2026 | $352.6M | -1.7% |
| Ended Dec 27, 2025 | $333.1M | +6.1% |
| Ended Jun 28, 2025 | $398.0M | +19.4% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Sep 27, 2025 | $1.5B | +9.9% |
| Ended Sep 28, 2024 | $1.3B | +18.9% |
| Ended Sep 30, 2023 | $1.1B | +41.5% |
| Ended Oct 1, 2022 | $800.6M | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Aug 31, 2026 observed Sep 8, 2026 filed · 8d Schedule 13G amendment | Reported accumulation | 3.2K +201 | 10.20% +0.70 pts | $58.15 | $63.71 | $56.29 |
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 1.4M | $56.29 | |||
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Schedule 13G amendment | Reported accumulation | 3.0K +476 | 9.50% -2.50 pts | $78.96 | $66.01 | $56.29 |
Compare BLBD with other securities showing similar institutional activity or recent accumulation across several tracked institutions.